SymBiosis Capital Partners, LLC
CIK 2006045 · View on SEC EDGAR ↗
- Portfolio value
- $52.8M
- Positions
- 6
- As of
- March 31, 2026 Data as of Q1 2026
Portfolio value QoQ: -51.8% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 5
- Effective number of positions
- 2.6
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q1 2026: 6.7% Est. buys $5,437,500 · sells $67,420,254
- New positions
- 1
- Increased
- 0
- Decreased
- 3
- Closed
- 6
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 96.1% · Options excluded: 0.0%
Sector breakdown
Full portfolio 6 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| EVMN Evommune, Inc. Common Stock | $29,445,086 | 55.80% | 1,280,778 | $7,518,167 | |||
| IVA Inventiva S.A. - American Depository Shares | $13,064,700 | 24.76% | 2,354,000 | $974,700 | Down ×1 | ||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $5,437,500 | 10.30% | 750,000 | Up ×1 | |||
| RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | $2,694,941 | 5.11% | 3,667,585 | $-5,810,059 | Down ×1 | ||
| CLNN Clene Inc. - Common Stock | $2,125,293 | 4.03% | 431,094 | $-2,397,513 | Down ×1 | ||
| SRZNW Surrozen, Inc. - Warrant | $2,400 | 0.00% | 150,000 | $-600 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| WVE | $5,437,500 | 750,000 | 10.30% |
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| VSTM | March 31, 2026 | 2,000,000 | $15,440,000 | 31.1% |
| AMPG | March 31, 2026 | 2,555,000 | $13,234,900 | 84.8% |
| PGEN | March 31, 2026 | 3,000,000 | $12,540,000 | 88.6% |
| NUVB | March 31, 2026 | 1,250,000 | $11,200,000 | 62.8% |
| AARD | March 31, 2026 | 476,595 | $6,255,309 | 61.3% |
| GBIO | March 31, 2026 | 665,000 | $3,777,200 | No longer tracked |